Delaware | 000-31191 | 04-3324394 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
8 Sylvan Way | ||
Parsippany, New Jersey | 07054 | |
(Address of Principal Executive Offices) | (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
(c) | Exhibits | ||
The following exhibits relating to Item 2.02 shall be deemed to be furnished, and not filed: |
99.1 | Press release dated July 29, 2009 entitled The Medicines Company
Reports Second Quarter 2009 Financial Results (incorporated by reference to Exhibit 99.1 of the Current Report on Form 8-K, filed on July 29, 2009) |
||
99.2 | Transcript of earnings release conference call held on July 29, 2009 | ||
99.3 | Conference Call Summary |
THE MEDICINES COMPANY |
||||
Date: July 31, 2009 | By: | /s/ Paul M. Antinori | ||
Paul M. Antinori | ||||
Senior Vice President and General Counsel |
Exhibit No. | Description | |
99.1
|
Press release dated July 29, 2009 entitled The Medicines
Company Reports Second Quarter 2009 Financial Results (incorporated by reference to Exhibit 99.1 of the Current Report on Form 8-K, filed on July 29, 2009) |
|
99.2
|
Transcript of earnings release conference call held on July 29, 2009 | |
99.3
|
Conference Call Summary |